Literature DB >> 10833178

Current approaches to the management of primary hyperoxaluria.

P Cochat1, O Basmaison.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10833178      PMCID： PMC1718347          DOI： 10.1136/adc.82.6.470

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  19 in total

Review 1.  What is new in primary hyperoxaluria?

Authors:  E Leumann; B Hoppe
Journal:  Nephrol Dial Transplant       Date:  1999-11       Impact factor: 5.992

Review 2.  Primary hyperoxaluria type 1.

Authors:  P Cochat
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

3.  Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT).

Authors:  A C Tarn; C von Schnakenburg; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  Primary hyperoxaluria in infants: medical, ethical, and economic issues.

Authors:  P Cochat; P C Koch Nogueira; M A Mahmoud; N V Jamieson; J I Scheinman; M O Rolland
Journal:  J Pediatr       Date:  1999-12       Impact factor: 4.406

Review 5.  Management of primary hyperoxaluria: efficacy of oral citrate administration.

Authors:  E Leumann; B Hoppe; T Neuhaus
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in primary hyperoxaluria type 1.

Authors:  C Toussaint; L De Pauw; A Vienne; P A Gevenois; J Quintin; M Gelin; J L Pasteels
Journal:  Am J Kidney Dis       Date:  1993-01       Impact factor: 8.860

7.  Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.

Authors:  D S Milliner; J T Eickholt; E J Bergstralh; D M Wilson; L H Smith
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

8.  The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.

Authors:  S D Cramer; P M Ferree; K Lin; D S Milliner; R P Holmes
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

Review 9.  Primary hyperoxaluria type I.

Authors:  K Latta; J Brodehl
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

10.  Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

Authors:  R W Watts; R Y Calne; R Williams; M A Mansell; N Veall; P Purkiss; K Rolles
Journal:  Q J Med       Date:  1985-10
View more
  5 in total

1.  Primary hyperoxaluria type 1 with a novel mutation.

Authors:  Sidharth Kumar Sethi; Hans R Waterham; Sonika Sharma; Alok Sharma; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

2.  Medical evaluation and management of urolithiasis.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Ther Adv Urol       Date:  2010-02

3.  The metabolic etiology of urolithiasis in Turkish children.

Authors:  Mustafa Bak; Rana Ural; Hasan Agin; Erkin Serdaroglu; Sebnem Calkavur
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

Review 4.  Nephrocalcinosis: A Review of Monogenic Causes and Insights They Provide into This Heterogeneous Condition.

Authors:  Fay J Dickson; John A Sayer
Journal:  Int J Mol Sci       Date:  2020-01-06       Impact factor: 5.923

5.  Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1.

Authors:  Benedetta Chiodini; Nathalie Tram; Brigitte Adams; Elise Hennaut; Ksenija Lolin; Khalid Ismaili
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.